Jihoon Jo
Overview
Explore the profile of Jihoon Jo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1670
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ko Y, Ryu Y, Han S, Park H, Choi M, Kim B, et al.
Mol Med
. 2024 Dec;
30(1):276.
PMID: 39725872
Background: Recent studies have identified hearing loss (HL) as a primary risk factor for Alzheimer's disease (AD) onset. However, the mechanisms linking HL to AD are not fully understood. This...
2.
Denoeud F, Godfroy O, Cruaud C, Heesch S, Nehr Z, Tadrent N, et al.
Cell
. 2024 Nov;
187(24):6943-6965.e39.
PMID: 39571576
Brown seaweeds are keystone species of coastal ecosystems, often forming extensive underwater forests, and are under considerable threat from climate change. In this study, analysis of multiple genomes has provided...
3.
Jo J, Park J, Won H, Jeong J, Jung T, Lee K, et al.
Sci Data
. 2024 Sep;
11(1):959.
PMID: 39242678
Sageretia thea, a notable species within the mock buckthorn genus, is recognized for its intriguing biogeographical distribution and diverse medicinal properties. Despite this significance, genomic studies on S. thea are...
4.
Choi S, Graf L, Choi J, Jo J, Boo G, Kawai H, et al.
Curr Biol
. 2024 Jan;
34(4):740-754.e4.
PMID: 38262417
Brown algae are the only group of heterokont protists exhibiting complex multicellularity. Since their origin, brown algae have adapted to various marine habitats, evolving diverse thallus morphologies and gamete types....
5.
Um J, Shin D, Choi S, Nathan A, Kim Y, Lee D, et al.
Theranostics
. 2024 Jan;
14(1):56-74.
PMID: 38164158
Promotion of mitophagy is considered a promising strategy for the treatment of neurodegenerative diseases including Alzheimer's disease (AD). The development of mitophagy-specific inducers with low toxicity and defined molecular mechanisms...
6.
Jo D, Arjunan A, Choi S, Jung Y, Park J, Jo J, et al.
Food Funct
. 2023 Oct;
14(21):9650-9670.
PMID: 37843873
Alzheimer's disease (AD) is a common neurodegenerative disease worldwide and is accompanied by memory deficits, personality changes, anxiety, depression, and social difficulties. For treatment of AD, many researchers have attempted...
7.
Jo J, Bae S, Jeon J, Youn H, Lee G, Ban C
Bioconjug Chem
. 2022 Dec;
34(1):238-247.
PMID: 36516871
As a counterpart to antibody-drug conjugates (ADCs), aptamer-drug conjugates (ApDCs) have been considered a promising strategy for targeted therapy due to the various benefits of aptamers. However, an aptamer merely...
8.
Park M, Park K, Choi B, Han W, Yoon H, Jung H, et al.
Proc Natl Acad Sci U S A
. 2022 Jan;
119(3).
PMID: 35027452
Alzheimer's disease (AD) is characterized by complex, multifactorial neuropathology, suggesting that small molecules targeting multiple neuropathological factors are likely required to successfully impact clinical progression. Acid sphingomyelinase (ASM) activation has...
9.
Lee Y, Wang M, Son Y, Yang E, Kang M, Kim H, et al.
Molecules
. 2021 Oct;
26(20).
PMID: 34684684
Memory deterioration in Alzheimer's disease (AD) is thought to be underpinned by aberrant amyloid β (Aβ) accumulation, which contributes to synaptic plasticity impairment. Avenanthramide-C (Avn-C), a polyphenol compound found predominantly...
10.
Wang M, Yoon G, Song J, Jo J
Sci Rep
. 2021 Apr;
11(1):8326.
PMID: 33859286
Metabolic syndrome, which increases the risk of obesity and type 2 diabetes has emerged as a significant issue worldwide. Recent studies have highlighted the relationship between metabolic imbalance and neurological...